ClinicalTrials.Veeva

Menu

Determination of Product Thickness Applied on Different Areas of the Face Using a Multispectral Imaging Method

Pierre Fabre logo

Pierre Fabre

Status

Completed

Conditions

Sunscreen

Treatments

Other: RV4369A cosmetic product

Study type

Observational

Funder types

Industry

Identifiers

NCT05837208
ADPROTECTPF

Details and patient eligibility

About

The aim of the study is to determine:

  • the thickness of the RV4369A truly applied on different areas of the face after single application of the product determined by a multispectral imaging method.
  • the influence of a second application of the product 15 to 30 minutes after the first application on the product thickness determined by multispectral imaging method.
  • the influence of the recommendations of use provided to the subjects before application of the product on the product thickness determined by multispectral imaging method .

Full description

This study is a monocentric, comparative, open study performed on the face and forearms of healthy adults.

Planning of the visits:

Visit 1: Inclusion visit (D1) Visit 2: End of study visit (D10), a window of +/- 2 days is allowed for this evaluation, * The theoretical study duration for each subject is 10 days. The maximal study duration for each subject is 12 days.

Enrollment

26 patients

Sex

All

Ages

20 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Dry, normal to combination skin
  • Phototype I to V inclusive.
  • Absence of significant facial hair.

Exclusion criteria

Population

  • Pregnant, breastfeeding women.
  • For men: moustached or bearded.
  • Substantial hair on the forearm and face.
  • Application of keratolytic or self-tanning products to the face, forearms and arms in the four weeks prior to inclusion.
  • With scars or other cutaneous characteristics, sunburn on forearms in the test areas, the size of which is considered incompatible with the study.
  • Application of water, cleansing or beauty products to the forearms and arms since the last wash on the evening before inclusion.

Diseases :

  • Known history of allergy to any of the investigational product ingredients.
  • Known history of allergy to latex.
  • Skin lesions or skin disease on the face or on the arms and forearms that may affect test results (seborrheic dermatitis, atopic dermatitis, psoriasis, acne, rosacea, etc.).

Treatments:

  • Ongoing local or Oral treatment (retinoids, anti-inflammatory) that may affect test results.

Trial design

26 participants in 1 patient group

Treated Group
Description:
all subjects will apply the study product RV4369A
Treatment:
Other: RV4369A cosmetic product

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems